Healthcare entity

CARA

Technology

Every one of those 1 sits in a single category, health-it. DIAGNOS Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 4.7 for the same window.

Last mentioned: Feb 26, 2026

Entity pulse

Recent coverage · CARA

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about CARA

Every one of those 1 sits in a single category, health-it. DIAGNOS Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 4.7 for the same window. The 5 average consequence score is below the beat benchmark of 5.6 in the same window. We currently track 1 Healthcare story that mention CARA, all published on February 26, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering CARA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Market Reporting

    Financial news outlets and analysts begin reporting on the company's performance.

  2. Earnings Release

    DIAGNOS Inc. issues financial results for the latest fiscal period.

  3. Strategic Expansion

    Ongoing rollout of the CARA platform in international markets including Saudi Arabia and Mexico.

Stories mentioning CARA 1

Health IT Neutral

DIAGNOS (DGNOF) Reports Earnings Amid Expanding AI Retinal Screening Demand

DIAGNOS Inc. (OTCMKTS: DGNOF) has released its latest financial results, highlighting the company's ongoing efforts to scale its AI-driven retinal screening platform. The results come as the healthcare industry increasingly adopts automated diagnostic tools to address the global rise in diabetic retinopathy and other vision-threatening conditions.

2 sources

Source: themarketsdaily.com · tickerreport.com

CARA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.